Pediatric renal tumors account for 3%–11% of childhood cancers, the most common of
which is Wilms tumor or nephroblastoma. Epidemiology plays a key role in cancer …

Pediatric renal cell carcinoma (RCC) is a rare type of kidney cancer, most commonly
occurring in teenagers and young adolescents. Few relatively large series of pediatric RCC …

BACKGROUND Renal cell carcinomas (RCCs) are rare in young patients. Knowledge of
their pathologic and molecular spectrum remains limited, and no prospective studies have …

MiTF/TFE translocation renal cell carcinoma (tRCC) is a rare and aggressive subtype of
RCC representing the most prevalent RCC in the pediatric population (up to 40%) and …

In children, renal cell carcinoma (RCC) is rare. This study is the first report of pediatric
patients with RCC registered by the International Society of Pediatric Oncology‐Renal …

The expansion of knowledge regarding driver mutations for Wilms tumor (WT) and malignant
rhabdoid tumor of the kidney (MRT) and various translocations for other pediatric renal …

Around 6% of all childhood malignancies represent renal tumors, of which a majority
includes Wilms tumor (WT). Although survival rates have improved over the last decades …

Malignant renal tumors account for 7% of childhood cancers, and Wilms tumors are by far
the most common—but not in older children and adolescents. Among individuals in the latter …

Renal tumors comprise approximately 7% of all malignant pediatric tumors. This is a highly
heterogeneous group of tumors, each with its own therapeutic management, outcome, and …

Background Axitinib is an oral small molecule that inhibits receptor tyrosine kinases vascular
endothelial growth factor receptors 1 to 3. A phase 1 and pharmacokinetic (PK) trial …